Visit

Patents

InterDigital reveals new licensing deal with Google secured through mystery platform

The agreement was struck after approach from unnamed broker and has been hailed by senior leadership at the company, but the identity of the organiser remains unknown

11 Nov 2019

It is time for the German courts to be courageous on FRAND

The Dusseldorf Court of Appeal’s decision in Unwired Planet v Huawei is one that had licensees cheering and licensors in despair - but it may not last long

9 Nov 2019

The patent dodgers trolling the IP landscape

IPCom is one of Europe’s oldest NPEs – and usually one of its most reticent. Not anymore, though. In this opinion piece, managing director Pio Suh explains why he believes firms such as his have a key role to play in FRAND licensing

Latest

View all

8 Nov 2019

Blackberry portfolio licensor inks RPX agreement and insists there’s still plenty more deals to do

Defensive aggregator closes transaction with Fundamental Innovation Systems International giving members coverage on USB charging patents; Apple also settles infringement case Read more

8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

8 Nov 2019

A snapshot of the global patent landscape in eight charts

A recently issued WIPO report based on multiple data points sheds light on the state of play in worldwide patenting activity Read more

7 Nov 2019

The USPTO's consultation on patent issues relating to AI seeks answers on key questions

Artificial intelligence has the potential to change the entire nature of the invention process and, therefore, the criteria under which patents are awarded Read more

News

View all

6 Nov 2019

New report reveals why SMEs want patents and the opportunities they bring

Study released by the European Patent Office sheds light on the growing sophistication of smaller businesses seeking protection for their inventions Read more

2 Nov 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators Read more

31 Oct 2019

IAM honours Asia’s IP leaders

The winners of our annual Asia IP Elite awards for the teams, deal and individual of the year were revealed before a sold-out crowd at IPBC Asia 2019 Read more

30 Oct 2019

IPBC Asia comes to a brilliant end in Tokyo

A hugely successful conference that attracted a record attendance is now over after a day of talk about 5G licensing, the Chinese and Japanese IP landscapes, data, litigation and a whole lot more Read more

Analysis

View all

7 Nov 2019

Multi-billion dollar IP dispute exposes dangers of life sciences collaborations

Seattle Genetics is demanding rights to Daiichi Sankyo’s potential blockbuster cancer treatment, which it says is an improvement on the proprietary technology included in their previous partnership Read more

7 Nov 2019

New suit suggests LG China licensing push

Korean company is the latest infrequent plaintiff to sue a Chinese TV maker, underlining challenges for licensors in the space Read more

6 Nov 2019

We’re keeping a very close eye on Arthrex, says Iancu at IAM event in Washington DC

Major Federal Circuit decision on PTAB judges leaves stakeholder community looking for answers and, possibly, to a statutory solution Read more

6 Nov 2019

Chinese patents surviving validity challenges in greater numbers

Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate Read more

Insights

View all

30 Aug 2019

Twitter

11 Nov 2019

@IAM_magazine InterDigital and Google close licensing deal through new platform $IDCC https://t.co/m87RqhZwjb https://t.co/viPmjMfSIw Read more

11 Nov 2019

@IAM_magazine Germany's courts have heard more FRAND-related cases than those of any other country, but unless they get more cour… https://t.co/Kmj7K018WM Read more

10 Nov 2019

@IAM_magazine RT @IAM_magazine: All the news, analysis, opinion and data that matters from the global IP market in this week’s IAM Sunday Supplement. htt… Read more

10 Nov 2019

@IAM_magazine All the news, analysis, opinion and data that matters from the global IP market in this week’s IAM Sunday Supplemen… https://t.co/kgcbkXlTyK Read more

Find an expert

Martin Wilming

Partner

Wil, Switzerland

Hepp Wenger Ryffel AG

View full biography

Patents

It is time for the German courts to be courageous on FRAND

The patent dodgers trolling the IP landscape

Latest

Blackberry portfolio licensor inks RPX agreement and insists there’s still plenty more deals to do

Catch up on the most important life sciences IP developments from the past month

A snapshot of the global patent landscape in eight charts

The USPTO's consultation on patent issues relating to AI seeks answers on key questions

News

New report reveals why SMEs want patents and the opportunities they bring

UK general election could result in a paradigm shift on pharma IP

IAM honours Asia’s IP leaders

IPBC Asia comes to a brilliant end in Tokyo

Analysis

Multi-billion dollar IP dispute exposes dangers of life sciences collaborations

New suit suggests LG China licensing push

We’re keeping a very close eye on Arthrex, says Iancu at IAM event in Washington DC

Chinese patents surviving validity challenges in greater numbers

Insights

IP market news highlights

IP market news highlights

Toyota showcases the dynamism of IP strategy in the auto sector

IP market news highlights

Trending

Blackberry portfolio licensor inks RPX agreement and insists there’s still plenty more deals to do

New report reveals why SMEs want patents and the opportunities they bring

TSMC chief speaks as market reacts to foundry war settlement

The Fed Circuit’s Arthrex decision is undoubtedly a blockbuster, now comes the fallout

Nokia builds on a different approach to drive more value from its patents

Twitter

Find an expert